(RTTNews) - InterContinental Hotels Group plc (IHG.L, IHG) reported Tuesday that its first-half loss before tax was $275 million, compared to profit of $375 million. Basic loss per share were 115.4 cents, compared to profit of 167.2 cents a year ago.
Bayer agreed to acquire British biotech firm KaNDy Therapeutics Ltd. for an initial $425 million to strengthen its women's healthcare business with a prospective non-hormonal treatment of menopausal symptoms.
The number of people in work in Britain fell by 220,000 in the three months to June, the most since 2009, as the coronavirus crisis hammered the number of self-employed, Office for National Statistics said.
Britain's FTSE 100 index is seen opening 46 points higher at 6,097 on Tuesday, according to financial bookmakers, with futures up 0.8% ahead of cash markets open.
Foreign investors were net buyers of Asian shares for a second straight month, helped by a recovery in regional economic activity and a surge in demand for technology shares.
Raiffeisen Bank International (RBI) on Tuesday posted a 44% slump in second-quarter profit, largely due to the economic impact of the pandemic in the countries in which it operates, but confirmed its 2020 targets.
(RTTNews) - Indian shares opened on a positive note Tuesday after the country's Covid-19 recoveries reached a "historic peak" of 1.5 million, with a recovery rate of almost 70 percent.
What happened
Shares of hydrogen-powered truck company Nikola (NASDAQ: NKLA) plummeted 55.6% in July, according to data from S&P Global Market Intelligence. The volatile stock began the month at more than $67 a share but ended it at just $30.
The dollar held overnight gains on Tuesday following seven weeks of an almost relentless fall as investors clung to hopes of a bipartisan stimulus deal in Washington and U.S. bond yields rebounded from multi-month lows.
What happened
Shares of online salvage auctioneer Copart (NASDAQ: CPRT)'s shares were up 12% for July, according to data from S&P Global Market Intelligence.
South Korea's Daewoong Pharmaceutical Co Ltd said on Tuesday it received Indian regulatory approval to test its anti-parasitic niclosamide drug to treat COVID-19 patients in an early-stage human trial.
Novavax (NASDAQ: NVAX) started off 2020 as a micro-cap. It was trading at $4 a share, and its market capitalization was barely over $100 million. The stock had dropped all the way down to penny-stock land. The biotech had no profits and no FDA-approved drugs. Most investors h
The California State Controller Betty Yee has called for the board of the California Public Employees' Retirement System (CalPERS), the largest public U.S. investment fund, to launch an inquiry into the abrupt exit of its chief investment officer.